Axogen Inc (AXGN) concluded trading on Thursday at a closing price of $15.57, with 0.49 million shares of worth about $7.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.50% during that period and on April 17, 2025 the price saw a loss of about -0.06%. Currently the company’s common shares owned by public are about 44.15M shares, out of which, 41.83M shares are available for trading.
Stock saw a price change of -1.46% in past 5 days and over the past one month there was a price change of -13.02%. Year-to-date (YTD), AXGN shares are showing a performance of -5.52% which increased to 122.43% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.55 but also hit the highest price of $21.00 during that period. The average intraday trading volume for Axogen Inc shares is 507.32K. The stock is currently trading -8.98% below its 20-day simple moving average (SMA20), while that difference is down -12.31% for SMA50 and it goes to 7.32% higher than SMA200.
Axogen Inc (NASDAQ: AXGN) currently have 44.15M outstanding shares and institutions hold larger chunk of about 82.07% of that.
The stock has a current market capitalization of $690.44M and its 3Y-monthly beta is at 1.23. It has posted earnings per share of -$0.23 in the same period. It has Quick Ratio of 2.16 while making debt-to-equity ratio of 0.66. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AXGN, volatility over the week remained 4.36% while standing at 5.86% over the month.
Stock’s fiscal year EPS is expected to rise by 115.62% while it is estimated to increase by 79.39% in next year. EPS is likely to grow at an annualized rate of 76.65% for next 5-years, compared to annual growth of 21.24% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Lake Street on March 17, 2025 offering a Buy rating for the stock and assigned a target price of $30 to it. Coverage by Raymond James stated Axogen Inc (AXGN) stock as an Outperform in their note to investors on July 01, 2024, suggesting a price target of $13 for the stock. On November 11, 2022, Jefferies Resumed their recommendations, while on May 09, 2022, Canaccord Genuity Upgrade their ratings for the stock with a price target of $15. Stock get an Overweight rating from Cantor Fitzgerald on March 11, 2022.
